Pacer Advisors, Inc. Dynavax Technologies Corp Transaction History

Pacer Advisors, Inc.

  • $41.8 Billion
  • Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Pacer Advisors, Inc. holds 7,491 shares of DVAX stock, worth $93,038. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,491
Previous 5,811 28.91%
Holding current value
$93,038
Previous $65,000 27.69%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$10.05 - $11.61 $16,884 - $19,504
1,680 Added 28.91%
7,491 $83,000
Q2 2024

Aug 13, 2024
SELL
$10.73 - $12.58 $27.9 Million - $32.7 Million
-2,596,435 Reduced 99.78%
5,811 $65,000
Q1 2024

May 10, 2024
BUY
$11.7 - $14.98 $30.4 Million - $39 Million
2,602,246 New
2,602,246 $32.3 Million
Q4 2022

Feb 06, 2023
BUY
$10.27 - $13.29 $2.53 Million - $3.28 Million
246,619 Added 37.66%
901,476 $9.59 Million
Q3 2022

Oct 18, 2022
SELL
$9.93 - $17.44 $2.52 Million - $4.43 Million
-254,162 Reduced 27.96%
654,857 $6.84 Million
Q2 2022

Aug 12, 2022
BUY
$7.45 - $12.83 $6.77 Million - $11.7 Million
909,019 New
909,019 $11.4 Million
Q2 2021

Jul 21, 2021
SELL
$7.25 - $10.99 $58,964 - $89,381
-8,133 Closed
0 $0
Q1 2021

Apr 05, 2021
SELL
$4.57 - $11.18 $48,633 - $118,977
-10,642 Reduced 56.68%
8,133 $80,000
Q4 2020

Jan 20, 2021
BUY
$3.73 - $5.6 $45,901 - $68,913
12,306 Added 190.23%
18,775 $84,000
Q3 2020

Oct 19, 2020
BUY
$4.32 - $11.7 $27,946 - $75,687
6,469 New
6,469 $28,000
Q4 2018

Feb 13, 2019
SELL
$8.14 - $13.28 $86,479 - $141,086
-10,624 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$11.85 - $16.0 $125,894 - $169,984
10,624 New
10,624 $132,000
Q1 2018

May 14, 2018
SELL
$14.65 - $19.9 $42,851 - $58,207
-2,925 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$17.3 - $24.08 $50,602 - $70,434
2,925
2,925 $55,000

Others Institutions Holding DVAX

# of Institutions
274
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email